Exagen (NASDAQ: XGN) grants Paul Kim 37,500 options at $4.31
Rhea-AI Filing Summary
EXAGEN INC. (XGN) reported that director Paul Kim received a grant of stock options. On 2026-06-09, he was awarded 37,500 stock options to purchase common stock at an exercise price of $4.31 per share, expiring on 2036-06-08. These options vest in full on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, subject to his continued board service. Following this grant, Kim holds 46,500 options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Kim Paul
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option(right to buy) F1 | 37,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option(right to buy) — 46,500 shares (Direct)
Footnotes (1)
- F1. The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Key Figures
Options granted: 37,500 options
Exercise price: $4.31 per share
Expiration date: 2036-06-08
+3 more
6 metrics
Options granted
37,500 options
Stock option grant to Paul Kim on 2026-06-09
Exercise price
$4.31 per share
Conversion or exercise price of granted stock options
Expiration date
2036-06-08
Expiration of the granted stock options
Underlying shares
37,500 shares
Common shares underlying the granted options
Total options after grant
46,500 options
Paul Kim’s derivative holdings following the reported transaction
Affirmed 10b5-1 plan status
false
Form-level checkbox for Rule 10b5-1(c) plan
Key Terms
Stock Option(right to buy), exercise price, vesting, annual meeting of the Issuer's stockholders
4 terms
Stock Option(right to buy) financial
"security_title: Stock Option(right to buy)"
exercise price financial
"conversion_or_exercise_price: 4.3100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"becomes fully vested and exercisable on the first to occur"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of the Issuer's stockholders financial
"or (b) the next occurring annual meeting of the Issuer's stockholders"
FAQ
What transaction did Paul Kim report on Form 4 for EXAGEN INC. (XGN)?
Paul Kim reported a grant of stock options from Exagen Inc. He received 37,500 options on 2026-06-09 to buy common stock, representing compensation rather than an open-market purchase or sale.
How many EXAGEN INC. (XGN) stock options were granted to Paul Kim and at what price?
Paul Kim was granted 37,500 stock options with an exercise price of $4.31 per share. These options give him the right to purchase Exagen common stock at that price until expiration if they vest and are exercised.
When do Paul Kim’s EXAGEN INC. (XGN) stock options vest?
All 37,500 options vest in full on the earlier of the first anniversary of the 2026-06-09 grant date or the next annual meeting of stockholders, provided Kim continues serving on Exagen’s board through the vesting date.
What is the expiration date of Paul Kim’s EXAGEN INC. (XGN) stock options?
The granted options expire on 2036-06-08. After that expiration date, any unexercised options will no longer be exercisable, so value can only be realized if exercised before this deadline subject to vesting conditions.
How many EXAGEN INC. (XGN) stock options does Paul Kim hold after this grant?
After the 37,500-option grant, Paul Kim directly holds 46,500 stock options in total. This figure reflects his derivative holdings reported following the transaction on the Form 4 filing for Exagen Inc.
Was Paul Kim’s EXAGEN INC. (XGN) Form 4 transaction under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as relying on a 10b5-1 plan. The reported transaction is a compensation-related option grant rather than a pre-arranged open-market trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
